HLA alleles associated with asparaginase hypersensitivity in Chinese children

[1]  S. Nasser,et al.  Polyethylene Glycol Induced Systemic Allergic Reactions (Anaphylaxis). , 2020, The journal of allergy and clinical immunology. In practice.

[2]  Mark M. Davis,et al.  Allergen-specific CD8+ T cells in peanut-allergic individuals. , 2019, The Journal of allergy and clinical immunology.

[3]  S. Mallal,et al.  The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[4]  M. Loh,et al.  Genome-wide analysis links NFATC2 with asparaginase hypersensitivity. , 2015, Blood.

[5]  K. Barnes,et al.  Genetics of allergic diseases. , 2015, Immunology and allergy clinics of North America.

[6]  M. Pino-Yanes,et al.  HLA-DRB1*15:01 allele protects from asthma susceptibility. , 2014, The Journal of allergy and clinical immunology.

[7]  M. Loh,et al.  HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergies. , 2014, Blood.

[8]  J. Shuster,et al.  Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: Results of Children's Oncology Group trial P9906 , 2011, Pediatric blood & cancer.

[9]  Chen-Yang Shen,et al.  Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan. , 2011, The New England journal of medicine.

[10]  E. Noguchi [Genetics of allergic diseases]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[11]  B. Sekerel,et al.  Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia. , 2009, The Journal of allergy and clinical immunology.

[12]  M. D. Boer,et al.  Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study , 2008, Leukemia.

[13]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[14]  R. Gelber,et al.  Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01. , 2001, Blood.